Discovery of an effective anti-inflammatory agent for inhibiting the activation of NF-κB

References

• Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846–852.
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Joseph K, Shibayama Y, Nakazawa Y, Ghebrehiwet B, Reddigari S, Silverberg M. Bradykinin formation—plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998;16(4):403–429.
   PubMed Web of Science ®Google Scholar
• Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14(6):433–439.
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Inflamm Res. 2022;15:3083–3094.
   PubMedGoogle Scholar
• Li QT, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol. 2002;2(10):725–734.
   PubMed Web of Science ®Google Scholar
• Zhang YD, Ma CY, Liu CS, Wu W. NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression. Life Sci. 2020;258:118093.
   PubMed Web of Science ®Google Scholar
• Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-κB in development and progression of human cancer. Transl Res. 2018;197:43–56.
   PubMed Web of Science ®Google Scholar
• Chen TL, Zhang XD, Zhu GL, Liu HF, Chen JR, Wang Y, He XL. Quercetin inhibits TNF-a induced HUVECs apoptosis and inflammation via downregulating NF-κB and AP-1 signaling pathway in vitro. Medicine (Baltimore). 2020;99(38):e22241.
   PubMed Web of Science ®Google Scholar
• Mitchell S, Vargas J, Hoffmann A. Signaling via the NF-κB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8(3):227–241.
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.
   PubMed Web of Science ®Google Scholar
• Ilchovska D, Barrow M. An overview of the NF-κB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-κB ligand RANKL and related nutritional interventions. Autoimmun Rev. 2021;20(2):102741.
   PubMed Web of Science ®Google Scholar
• Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-κB: An essential transcription factor in psoriasis. J Dermatol Sci. 2013;69(2):89–94.
   PubMed Web of Science ®Google Scholar
• Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Rama Raju Allam VS, Jha NK, et al. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021;345:109568.
   PubMed Web of Science ®Google Scholar
• Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A. The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF-kappaB pathway. Phytother Res. 2021;35(2):835–845.
   PubMed Web of Science ®Google Scholar
• Fernández Y, Miller TP, Denoyelle C, Esteban JA, Tang W-H, Bengston AL, Soengas MS. Chemical Blockage of the Proteasome Inhibitory Function of Bortezomib. J Biol Chem. 2006;281(2):1107–1118.
   PubMed Web of Science ®Google Scholar
• Lin M, Li L, Li L, Pokhrel G, Qi G, Rong R, Zhu T. The protective effect of baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med. 2014;14:19.
   PubMed Web of Science ®Google Scholar
• Cerna D, Li H, Flaherty S, Takebe N, Coleman CN, Yoo SS. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner. J Biol Chem. 2012;287(26):22408–22417.
   PubMed Web of Science ®Google Scholar
• Nakshatri H, Appaiah HN, Anjanapp M, Gilley D, Tanaka H, Badve S, Crooks PA, Mathews W, Sweeney C, Bhat-Nakshatri P. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Cell Death Dis. 2015;6(1):e1608.
   PubMedGoogle Scholar
• Welters ID, Fimiani C, Bilfinger TV, Stefano GB. NF-κB, nitric oxide and opiate signaling. Med Hypotheses. 2000;54(2):263–268.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 2003;54(4):469–487.
   PubMed Web of Science ®Google Scholar
• Ghasemi M. Nitric oxide: antidepressant mechanisms and inflammation. Adv Pharmacol. 2019;86:121–152.
   PubMedGoogle Scholar
• Kanchana US, Diana EJ, Mathew TV, Anilkumar G. Cyclodextrin based palladium catalysts for Suzuki reaction. Carbohydr Res. 2020;489:107954.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski J, Liu B, Tee DHY, Chen G, Ahmad NHB, Wong YX, Poh ZY, Ang SH, Tan ESW, Ong EH, et al. Fragment-based drug discovery of potent protein kinase C iota inhibitors. J Med Chem. 2018;61(10):4386–4396.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neria Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621–663.
   PubMed Web of Science ®Google Scholar
• Valovka T, Hottiger MO. p65 controls NF-κB activity by regulating cellular localization of IκBβ. Biochem J. 2011;434(2):253–263.
   PubMedGoogle Scholar
• Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13(9):679–692.
   PubMed Web of Science ®Google Scholar
• Hsia C-H, Jayakumar T, Lu W-J, Sheu J-R, Hsia C-W, Saravana Bhavan P, Manubolu M, Huang W-C, Chang Y. Auraptene, a monoterpene coumarin, inhibits LTA-induced inflammatory mediators via modulating NF-κB/MAPKs signaling pathways. Evid Based Complement Alternat Med. 2021;2021:5319584.
   PubMed Web of Science ®Google Scholar
• Rapôso C, Luna R. L D A, Nunes AKS, Thomé R, Peixoto CA. Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes. Brain Res Bull. 2014;104:60–73.
   PubMed Web of Science ®Google Scholar
• Mingghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004;63(9):901–910.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Regulation of NF-κB by TNF family cytokines. Semin Immunol. 2014;26(3):253–266.
   PubMed Web of Science ®Google Scholar
• KobayashiNagino SM, Komatsu S, Naruse AK, Nimura Y, Nakanishi M, Sokabe M. Stretch-induced IL-6 secretion from endothelial cells requires NF-κB activation. Biochem Biophys Res Commun. 2003;308(2):306–312.
   PubMed Web of Science ®Google Scholar
• Ma YF, Tang T, Sheng LL, Wang ZQ, Tao H, Zhang Q, Zhang Y, Qi ZL. Aloin suppresses lipopolysaccharide-induced inflammation by inhibiting JAK1-STAT1/3 activation and ROS production in RAW264.7 cells. Int J Mol Med. 2018;42(4):1925–1934.
   PubMed Web of Science ®Google Scholar